Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder

• Status: Recruiting
• Trial end date: 2022-03-30
• Target enrollment: 0
• Participant gender: All

Summary

The clinical study evaluates in an open-label, crossover design the comparative efficacy and safety of intranasal oxytocin and autologous umbilical cord blood for improving the functioning of children with autistic spectrum disorder

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Fundatia Bio-Forum
• Collaborator: Spitalul Angiomedica
• Treatments: Oxytocin

Criteria

Inclusion Criteria:

• diagnosis of autistic spectrum disorder

Exclusion Criteria:

• metabolic or genetic disorder (ex storage disease, Down, etc),